The global non-mydriatic fundus camera market was valued at USD 251.8 Million in 2022 and is expected to reach USD 563.1 Million by 2033. The hand-held non-mydriatic fundus camera with around 56.2% in terms of value share, has topped the global market within the product category in 2022 and is expected to grow at a CAGR of close to 7.8% over the forecast period (2023 to 2033)
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 251.8 Million |
| Market Value 2023 | USD 269.2 Million |
| Market Value 2033 | USD 563.1 Million |
| CAGR 2023 to 2033 | 7.7% |
| Market Share of Top 5 Countries | 44.3% |
| Key Market Players | Canon Medical Systems; Carl Zeiss; Centervue, Inc.; Chongqing Vision Star Optical Co., Ltd.; Forus Health Pvt Ltd; Guardion Health Sciences, Inc.; HAAG-STREIT GROUP; Huvitz Corp; ICEN Technology Company Limited; Kowa American Corporation; Nanjing Redsun Optical Co., Ltd.; NIDEK CO., LTD.; OPTOVUE, INC.; Remidio Innovative Solutions Pvt Ltd; Remidio Innovative Solutions Pvt Ltd.; Topcon Corporation; Topcon Medical Systems, Inc. & Volk Optical. |
Non-mydriatic fundus camera is an easy to use ophthalmic device utilized for examining ocular fundus in non-ophthalmology settings. The device is routinely used to screen eye disease among patients with high-risk of vision loss or blindness such as diabetic retinopathy.
The prevalence of eye diseases such as diabetic retinopathy and age-related macular degeneration is on the rise globally due to factors like an aging population, sedentary lifestyles, and the increasing incidence of chronic conditions like diabetes. This drives the demand for non-mydriatic fundus cameras for early detection and effective management of these diseases.
Advances in imaging technology have led to the development of high-resolution, easy-to-use non-mydriatic fundus cameras. These devices offer improved image quality, faster image capture, and enhanced diagnostic capabilities, which are appealing to healthcare professionals and contribute to market growth.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The global market for non-mydriatic fundus camera was around 5.3% of the overall USD 3.8 Billion of the global optical imaging market in 2022.
The rising prevalence of eye diseases such as diabetic retinopathy, age-related macular degeneration, and glaucoma has contributed to the growing demand for non-mydriatic fundus cameras. These cameras play a crucial role in early detection, diagnosis, and monitoring of these conditions, leading to increased sales.
As per Glaucoma Research Foundation 2023 statistics, currently 80 million people worldwide suffer from glaucoma condition, wherein more than half of affected people do not know about it. By the 2040, 22 million glaucoma patient will suffer from blindness.
There is a growing awareness among individuals and healthcare organizations about the importance of regular eye examinations and early detection of eye diseases. Preventive eye care initiatives and campaigns by governments and healthcare organizations have fuelled the demand for non-mydriatic fundus cameras, as they enable efficient and non-invasive screening, thereby reducing the burden of eye diseases and driving sales growth.
The expansion of healthcare infrastructure, particularly in emerging economies, has created opportunities for the adoption of advanced diagnostic equipment like non-mydriatic fundus cameras. Improved access to healthcare facilities and increasing investments in healthcare have boosted the sales of these devices in various regions.
Owed to the above factors, the global market is projected to grow at CAGR of 7.7% in forecast period.
There is significant potential for market growth in emerging economies. These regions often have a large population base and an increasing focus on improving healthcare infrastructure. As access to eye care services expands in these markets, there will be a higher demand for non-mydriatic fundus cameras, presenting opportunities for market expansion.
Continued research and development efforts have led to advancements in non-mydriatic fundus camera technology. Innovations such as higher image resolution, enhanced image analysis algorithms, and integration with artificial intelligence (AI) further improves diagnostic capabilities.
Companies have thus, been investing in research and development to gain competitive edge and seize opportunities for market growth.
The adoption of telemedicine and remote healthcare services has surged in recent years, driven by advancements in technology and the need for accessible healthcare.
Non-mydriatic fundus cameras have been utilized as part of telemedicine platforms, allowing remote diagnosis and monitoring of eye conditions. The integration of fundus cameras with telemedicine services opens up new opportunities for market growth.
The integration of artificial intelligence (AI) capabilities with non-mydriatic fundus cameras can also provide unique opportunities.
AI algorithms assist in automated image analysis, early disease detection, and decision support systems. By leveraging AI, non-mydriatic fundus cameras can enhance diagnostic accuracy, improve efficiency, and enable personalized patient care.
Non-mydriatic fundus cameras as diagnostic equipment can be relatively expensive, especially those equipped with advanced imaging technology and features.
Particularly in regions with limited healthcare budgets or resource-constrained healthcare settings, high cost of devices might limit their adoption. Affordability remains a significant restraint, hindering market penetration and widespread use.
Non-mydriatic fundus cameras employ advanced imaging technologies and require specialized training for efficient and accurate usage. Healthcare professionals, particularly in primary care settings, may face a challenge in operating and interpreting images from these devices. The need for training and technical expertise can slow down adoption and utilization.
Integrating non-mydriatic fundus cameras with existing healthcare systems, electronic health records (EHR), and telemedicine platforms can be challenging. Interoperability issues, data management, and compatibility with different systems can hinder seamless integration. Overcoming these challenges is necessary to ensure smooth workflow integration and maximize the benefits of these devices.
The USA occupies 22.2% of market share in 2022 globally. The United States is known for its innovation and adoption of advanced medical technologies. This extends to the non-mydriatic fundus camera market, with companies developing state-of-the-art devices with high-resolution imaging, advanced image analysis algorithms, and integration with electronic health records (EHR).
Technological advancements and continuous research and development efforts drive market growth and set trends for the industry.
The growing cases of USA population suffering from one of many ophthalmic conditions have significantly contributed to the expansion of non-mydriatic fundus camera market in this region.
This makes USA prominent market for non-mydriatic fundus camera in North America.
Japan held a significant value share in East Asia and is set to grow at a CAGR of 6.4% over the forecast period. Japan has a large and aging population, which contributes to a significant market size for non-mydriatic fundus cameras.
The prevalence of eye diseases such as diabetic retinopathy, age-related macular degeneration, and glaucoma is increasing in Japan, driving the demand for non-mydriatic fundus cameras for early detection and monitoring.
Japan has a well-developed healthcare infrastructure, including hospitals, clinics, and specialized eye care facilities. These institutions provide opportunities for the adoption and utilization of non-mydriatic fundus cameras for eye examinations, disease screening, and management.
In 2022, the China held a significant share in the East Asia market and contributed around USD 14.4 Million. The Chinese government has implemented various initiatives to improve healthcare services and expand access to quality eye care.
The government's focus on promoting preventive healthcare, early disease detection, and the treatment of eye conditions has led to increased adoption of non-mydriatic fundus cameras in the country.
The non-mydriatic fundus camera market in China is competitive, with both domestic and international manufacturers vying for market share. Chinese companies are gaining traction with their local expertise, competitive pricing, and targeted marketing strategies.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
By product, hand-held non-mydriatic fundus cameras held 56.2% market share in world in 2022. Like other non-mydriatic fundus cameras, hand-held devices capture high-resolution images of the retina without the need for pupil dilation.
This makes the examination more comfortable for patients, eliminates the waiting time associated with dilation, and enables quick and efficient imaging.
The market value of CMOS sensor is USD 112.3 Million, representing a sizable 44.6% market share in 2022. CMOS sensors often have built-in image processing capabilities directly on the sensor chip.
This enables real-time image enhancement, noise reduction, and other computational adjustments, improving the quality of the captured fundus images without the need for extensive post-processing.
CMOS sensors consume less power than CCD sensors, making them more energy-efficient. This is especially beneficial in handheld or portable non-mydriatic fundus cameras, as it extends the battery life and enables longer periods of continuous operation.
The hospitals have a considerable presence in the non-mydriatic fundus camera market, accounting for 41.9% value share in 2022, and exhibiting a high CAGR of 7.6% over the forecast period.
Non-mydriatic fundus cameras can be seamlessly integrated with electronic health record systems used in hospitals. This integration facilitates efficient storage, retrieval, and sharing of patient retinal images, enabling healthcare professionals to access the images as part of the patient's medical records.
This enhances continuity of care and ensures that the retinal images are readily available for future reference, comparison, or collaboration with other healthcare providers.
Collaborations and partnerships among healthcare providers, research institutions, and technology driven companies have encouraged innovation and hastened non-mydriatic fundus camera based developments.
Collaboration in research, development, and commercialization have lead to market expansion and the creation of new devices & applications. Numerous large firms compete in the field of non-mydriatic fundus camera. Among the well-known players in this field are:
| Attributes | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2012 to 2022 |
| Market Analysis | USD Million for Value, Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Spain, BENELUX, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC countries, Türkiye, Northern Africa and South Africa. |
| Key Market Segments Covered | Product, Sensor Technology, End User, and Region |
| Key Companies Profiled | Canon Medical Systems, USA.; Carl Zeiss; Centervue, Inc.; Chongqing Vision Star Optical Co., Ltd.; Forus Health Pvt Ltd,; Guardion Health Sciences, Inc.; HAAG-STREIT GROUP; Huvitz Corp; ICEN Technology Company Limited; Kowa American Corporation; Nanjing Redsun Optical Co., Ltd.; NIDEK CO., LTD.; OPTOVUE, INC.; Remidio Innovative Solutions Pvt Ltd.; Remidio Innovative Solutions Pvt Ltd.; Topcon Corporation; Topcon Medical Systems, Inc.; Volk Optical |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The net worth of the global market could reach USD 563.1 million by 2033.
The share of top 5 countries was figured out to be 44.3% in 2022.
The overall market progressed at 5.3% CAGR from 2012 to 2022.
Advancements in imaging technology has boosted the sales of such cameras.
The United States leads as it acquired 22.2% of the global market in 2022.
| Estimated Size, 2024 | USD 976.8 million |
|---|---|
| Projected Size, 2034 | USD 1,561.0 million |
| Value-based CAGR (2024 to 2034) | 4.8% |
| Estimated Market Size, 2024 | USD 3,439.00 million |
|---|---|
| Projected Market Size, 2034 | USD 4,851.00 million |
| Value-based CAGR (2024 to 2034) | 3.50% |
| Estimated Market Size (2024E) | USD 1,465.4 million |
|---|---|
| Projected Industry Value (2034F) | USD 2,319.6 million |
| Value-based CAGR (2024 to 2034) | 4.7% |
| Market Value (2023) | USD 317.7 million |
|---|---|
| Market Expected Value (2033) | USD 507.9 million |
| Market Projected CAGR (2023 to 2033) | 4.8% |
Explore Diagnostic Devices Insights
View Reports
Non-mydriatic Fundus Camera Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
